BPG is committed to discovery and dissemination of knowledge
Randomized Controlled Trial
©Author(s) (or their employer(s)) 2026.
World J Clin Pediatr. Mar 9, 2026; 15(1): 109864
Published online Mar 9, 2026. doi: 10.5409/wjcp.v15.i1.109864
Table 5 Subgroup analysis of patients with compensated shock and hypotensive shock
Parameters
Patients with compensated shock (n = 16)
Patients with hypotensive shock (n = 33)
Group I-1 (n = 8)
Group F-1 (n = 8)
P value
Group I-2 (n = 16)
Group F-2 (n = 17)
P value
Patients who had resolution of shock8/8 (100)8/8 (100)116/16 (100)11/17 (64.70)0.018
Time of resolution of shock, minutes80.63 (25.05)125.63 (54.34)0.05285.66 (49.04)110.23 (30.81), n = 110.154
VIS for resolution of shock30.00 (13.09)21.25 (9.90)0.16131.56 (15.02)42.73 (32.59), n = 110.24
Mean fluid required within 6 h, mL/kg0 (0), n = 027.50 (8.86)28.00 (11.80), n = 531.76 (13.80)
Signs of fluid overload0/8 (0)4/8 (50.00)1/16 (6.25)12/17 (70.00)0
Duration of inotropes, hours68.00 (36.00-111.75)70.50 (17.36-102.00)0.574113.52 (88.70)37.82 (34.62)0.003
Duration of ventilation, hours109.00 (37.25-138.00), n = 450.00 (13.00-222.00), n = 50.55676.00 (18.00-144.00), n = 1122.50 (10.00-85.50), n = 140.222
Length of hospital stay, days11.00 (4.06-20.00)12.00 (7.25-22.50)0.5749.50 (3.88-23.50)1.58 (0.89-15.00)0.094
Maximum VIS during hospital stay48.75 (36.82)42.50 (37.70)0.74285.31 (48.35)103.53 (70.71)0.397
Mortality at 48 h1/8 (12.50)0/8 (0)3/16 (18.75)9/17 (52.94)0.041
Discharge; death4 (50.00); 4 (50.00)6 (75.00); 2 (25.00)0.6088 (50.00); 8 (50.00)7 (41.20); 10 (58.80)0.732


Write to the Help Desk